BAP1, functioning as a chromatin regulator, has been found to regulate the expression of lncRNA NEAT-1, impacting gemcitabine sensitivity in CCA cells through epigenetic mechanisms. This evidence concerns the gene BAP1 and cholangiocarcinoma.